Bank of New York Mellon’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-800
Closed -$2.76K 4100
2024
Q3
$2.76K Hold
800
﹤0.01% 4080
2024
Q2
$4.06K Hold
800
﹤0.01% 4108
2024
Q1
$6.77K Hold
800
﹤0.01% 4123
2023
Q4
$3.27K Hold
800
﹤0.01% 4290
2023
Q3
$2.4K Hold
800
﹤0.01% 4327
2023
Q2
$24.7K Hold
800
﹤0.01% 4258
2023
Q1
$39.6K Hold
800
﹤0.01% 4228
2022
Q4
$19.7K Buy
800
+31
+4% +$762 ﹤0.01% 4357
2022
Q3
$51K Hold
769
﹤0.01% 4319
2022
Q2
$32K Sell
769
-48
-6% -$2K ﹤0.01% 4434
2022
Q1
$41K Hold
817
﹤0.01% 4547
2021
Q4
$49K Sell
817
-243
-23% -$14.6K ﹤0.01% 4503
2021
Q3
$52K Hold
1,060
﹤0.01% 4426
2021
Q2
$61K Sell
1,060
-4,846
-82% -$279K ﹤0.01% 4292
2021
Q1
$339K Sell
5,906
-51
-0.9% -$2.93K ﹤0.01% 3855
2020
Q4
$404K Sell
5,957
-54
-0.9% -$3.66K ﹤0.01% 3716
2020
Q3
$1.53M Buy
6,011
+1,132
+23% +$287K ﹤0.01% 2842
2020
Q2
$820K Buy
4,879
+3,980
+443% +$669K ﹤0.01% 3215
2020
Q1
$63K Buy
899
+52
+6% +$3.64K ﹤0.01% 3931
2019
Q4
$54K Sell
847
-117
-12% -$7.46K ﹤0.01% 4097
2019
Q3
$56K Hold
964
﹤0.01% 4095
2019
Q2
$57K Hold
964
﹤0.01% 4096
2019
Q1
$63K Sell
964
-27
-3% -$1.77K ﹤0.01% 4061
2018
Q4
$53K Hold
991
﹤0.01% 4047
2018
Q3
$57K Sell
991
-1
-0.1% -$58 ﹤0.01% 4092
2018
Q2
$58K Sell
992
-256
-21% -$15K ﹤0.01% 4066
2018
Q1
$59K Buy
1,248
+256
+26% +$12.1K ﹤0.01% 4133
2017
Q4
$58K Hold
992
﹤0.01% 4168
2017
Q3
$61K Hold
992
﹤0.01% 4074
2017
Q2
$62K Hold
992
﹤0.01% 4103
2017
Q1
$63K Sell
992
-32
-3% -$2.03K ﹤0.01% 4104
2016
Q4
$39K Sell
1,024
-25
-2% -$952 ﹤0.01% 4156
2016
Q3
$38K Sell
1,049
-166
-14% -$6.01K ﹤0.01% 4167
2016
Q2
$44K Sell
1,215
-12
-1% -$435 ﹤0.01% 4189
2016
Q1
$49K Buy
1,227
+12
+1% +$479 ﹤0.01% 4084
2015
Q4
$52K Hold
1,215
﹤0.01% 4145
2015
Q3
$42K Hold
1,215
﹤0.01% 4211
2015
Q2
$66K Buy
1,215
+48
+4% +$2.61K ﹤0.01% 4120
2015
Q1
$78K Buy
+1,167
New +$78K ﹤0.01% 4088